20//02//12
Biotech event: Breakfast Briefing From QMB
QMB explores the answers
Press Release 17 April 2012
QMB Innovation Centre
(“QMB” or “the Innovation Centre”)
Where next for Biotech?
QMB host Biotech Breakfast Briefing
Queen Mary BioEnterprises (QMB) Innovation Centre, London’s highest specification incubator facilities for start-up and early stage life science businesses, is pleased to announce that it will be hosting its first Biotech Breakfast Briefing of 2012. The event, sponsored by global professional service providers PwC and Dorsey & Whitney LLP,will take place on 17th April 2012 from 8.30 to 9.30 at the QMB Innovation Centre (5 Walden Street, London E1 2AL).
This event, which is the second in the Biotech Breakfast series of events, also follows QMB’s highly successful Biotech Investor Forum in October last year. The event is set to look at Biotech and the health of its current business model.
The event, chaired by Frances Doherty, Partner at Dorsey & Whitney LLP and Jo Pisani, Partner at PwC, will cover multiple facets that have played a part in breaking the biotech model over the last few years, and also looking towards 2012, and what trends we can expect to see over the year. Other panel members include Brian Horsburgh, Head of Life Sciences at IP Group, Sacha Mann, Principal at Inventages and another panel member who is yet to be confirmed.
Simone Reid, Business Development Director of QMB, commented: “We are extremely excited about hosting another Biotech Breakfast series event at QMB Innovation Centre. Last year we hosted several successful events, bringing together a whole host of individuals who are passionate about the biotech sector. This event will be no different, offering attendees the opportunity to explore the current state of the sector, their thoughts on how the industry should move forward and perspectives from professionals within the sector.
“While QMB is already home to some of the UK’s newest and most exciting biotech and science companies, this event and others also make it a cluster for ideas and entrepreneurialism.”
-Ends-
For further information
Queen Mary BioEnterprises (QMB) Innovation Centre
Simone Reid
simone.reid@qmul.ac.uk
Tel: +44 (0)20 7882 8950
Media Enquiries
Abchurch Communications
Adam Michael / Oliver Hibberd
QMB@abchurch-group.com
Tel: +44 (0)20 7398 7714
Notes to Editors
About Queen Mary Bioenterprises Limited
The QMB Innovation Centre provides state of the art, customisable laboratory and
office space within minutes of The City of London. QMB provides business incubation support for new ventures and aims to become a hub for science and technology entrepreneurs in London. It provides all its clients with access to the wide range of professional services required when spinning a company out of academia and supports them through the critical phases of their development. The Innovation Centre’s proximity to the City of London means that it is well placed for clients to meet with the UK investment community and other advisers.
The 39,000 square foot facility comprises three floors of flexible work space for R&D
focussed companies, from start-ups to larger 'follow on' companies. The labs have a computer controlled air handling system that allows tuning of lab air pressure regimes. The labs also have pre-positioned above ceiling ducting to ease the connection of fume cupboards. This makes QMB an ideal location for a broad range of companies, stretching from biotechs to pure chemistry plays.
The Innovation Centre has a 120 seat lecture theatre and regularly hosts seminars and conferences which aim to promote the growth of the biotechnology industry in the UK.
QMB’s keystone tenant is Retroscreen Virology Ltd, a virology contract research
organisation, whose bespoke facilities in the Innovation Centre include laboratory
space and capacity to run clinical trials. QMB has recently signed up three tenant
companies to the facility; they are iGene London, Mediwise and DUVAS Technologies, who are all housed on the first floor. The QMB Innovation Centre is a wholly owned company of Queen Mary, University of London. It is the culmination of a four-year capital investment partnership between Queen Mary and the London Development Agency.
Document: QMB Biotech breakfast session (165 kb)